Atherosclerotic carotid disease. Experience at the National Institute of Neurology and Neurosurgery in patients undergoing carotid angioplasty with stent
DOI:
https://doi.org/10.31157/an.v19i3.47Keywords:
carotid atherosclerotic disease, angioplasty, stent, cerebral ischemia.Abstract
The carotid atherosclerotic disease (CD) is a common global entity, with a prevalence of approximately 55 to 60%, being more frequent in patients over 60 years, with no significant differences between gender. The moderate-severe CAD (stenosis> 50%) accounts for about 15% of cases of stroke and up to 50% of transient ischemic episodes. It also identified by carotid bruits in asymptomatic persons (without presenting symptoms of cerebral ischemia). Treatment consisting of antiplatelet, statin use and control of risk factors; but sometimes invasive treatment (endarterectomy vs stenting) is required. Carotid angioplasty may be superior to carotid endarterectomy in a group of patients, such as those previously undergone neck surgery or radiation.Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
This work is licensed under a Creative Commons Attribution 4.0 International License.
September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.